Form 4: SpringWorks Therapeutics Director Hambleton Receives Stock Grant, Disposes of Shares

Director Julie Hambleton received 10,060 shares of SpringWorks Therapeutics restricted stock units and disposed of 14,155 shares on May 14, 2025.

Summary

• On May 14, 2025, Julie Hambleton, a director of SpringWorks Therapeutics, received 10,060 shares of common stock in the form of restricted stock units (RSUs).
• The RSUs were granted under the company's Amended and Restated Non-Employee Director Compensation Policy.
• These RSUs will vest fully on the earlier of May 14, 2026, or the date of the next annual meeting of stockholders, contingent upon continued service to the Issuer.
• Hambleton also disposed of 14,155 shares of common stock on the same day.
• Following these transactions, Hambleton beneficially owns 14,155 shares of SpringWorks Therapeutics stock.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing detailing stock transactions by a company director. It doesn't contain information that would significantly sway investor sentiment positively or negatively.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's long-term success.

Future Outlook

The RSUs will vest on the earlier of May 14, 2026, or the next annual meeting of stockholders, subject to continued service to the Issuer by the Reporting Person.

Industry Context

This is a standard Form 4 filing, reflecting changes in beneficial ownership by a company insider. Such filings are common and provide transparency to the market regarding insider transactions.

Stakeholder Impact

• The stock grant to a director aligns their interests with those of the shareholders.

Key Dates

Keywords

SpringWorks Therapeutics, Director, Stock Grant, RSU, Beneficial Ownership, SWTX